| Literature DB >> 26392507 |
Marjolaine Morgand1, Blandine Rammaert1, Sylvain Poirée2, Marie-Elisabeth Bougnoux3, Hugo Tran4, Romain Kania4, Fabrice Chrétien5, Gregory Jouvion6, Olivier Lortholary7.
Abstract
Invasive aspergillosis (IA) is a severe disseminated fungal disease that occurs mostly in immunocompromised patients. However, central nervous system IA, combining meningitis and skull base involvement, does not occur only in groups with classic risk factors for IA; patients with chronic renal failure and diabetes mellitus are also at risk for more chronic forms. In both of our proven IA cases, voriconazole monotherapy was effective without surgery, and cerebrospinal fluid and serum 1,3-β-d-glucan test results were initially positive, in contrast to galactomannan antigen results.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26392507 PMCID: PMC4649149 DOI: 10.1128/AAC.01506-15
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191